See the DrugPatentWatch profile for tigecycline

Liver Function Tests with Tigecycline Use: A Comprehensive Review

As a broad-spectrum antibiotic, tigecycline is used to treat a range of infections, including complicated intra-abdominal infections, community-acquired pneumonia, and skin and skin structure infections. However, like all medications, tigecycline can have potential side effects, including liver damage. In this article, we will explore the recommended liver function tests (LFTs) associated with tigecycline use.

What is Tigecycline?

Tigecycline is a glycylcycline antibiotic that was approved by the FDA in 2005 for the treatment of complicated intra-abdominal infections. It works by inhibiting protein synthesis in bacteria, ultimately leading to bacterial death. Tigecycline is administered intravenously and is available in a single-dose vial.

Liver Function Tests: Why are they Important?

Liver function tests (LFTs) are essential in monitoring the health of the liver and detecting potential liver damage. LFTs measure the levels of various enzymes and proteins in the blood that are produced by the liver. These tests can help identify liver damage, inflammation, or disease, allowing for prompt treatment and minimizing potential complications.

Recommended Liver Function Tests with Tigecycline Use

The FDA recommends monitoring liver function in patients receiving tigecycline. The following LFTs are recommended:

* Alanine Aminotransferase (ALT): This enzyme is released into the bloodstream when liver cells are damaged. Elevated ALT levels can indicate liver damage or inflammation.
* Aspartate Aminotransferase (AST): Like ALT, AST is an enzyme that is released into the bloodstream when liver cells are damaged. Elevated AST levels can indicate liver damage or inflammation.
* Total Bilirubin: Bilirubin is a pigment produced by the liver that is responsible for the yellow color of bile. Elevated bilirubin levels can indicate liver damage or disease.
* Alkaline Phosphatase (ALP): This enzyme is produced by the liver and bones. Elevated ALP levels can indicate liver damage or disease.

Interpretation of Liver Function Tests

When interpreting LFT results, it's essential to consider the patient's medical history, medications, and other factors that may affect liver function. The following are general guidelines for interpreting LFT results:

* Normal LFTs: ALT and AST levels should be within the normal range (0-40 IU/L).
* Mildly Elevated LFTs: ALT and AST levels between 41-100 IU/L may indicate mild liver damage or inflammation.
* Moderately Elevated LFTs: ALT and AST levels between 101-200 IU/L may indicate moderate liver damage or inflammation.
* Severely Elevated LFTs: ALT and AST levels above 200 IU/L may indicate severe liver damage or inflammation.

Monitoring Liver Function with Tigecycline Use

The FDA recommends monitoring liver function in patients receiving tigecycline, particularly during the first 2 weeks of treatment. LFTs should be performed at baseline, 2-4 days after initiation of therapy, and then weekly for the duration of treatment.

Expert Insights

According to Dr. David H. Henry, a clinical pharmacologist at the University of California, San Francisco, "Monitoring liver function is essential when using tigecycline, particularly in patients with pre-existing liver disease or those receiving other medications that may affect liver function."

Conclusion

In conclusion, liver function tests are essential in monitoring the health of the liver and detecting potential liver damage associated with tigecycline use. The recommended LFTs include ALT, AST, total bilirubin, and ALP. Monitoring liver function is crucial, particularly during the first 2 weeks of treatment, to minimize potential complications.

Key Takeaways

* Tigecycline can cause liver damage, and monitoring liver function is essential.
* The recommended LFTs include ALT, AST, total bilirubin, and ALP.
* LFTs should be performed at baseline, 2-4 days after initiation of therapy, and then weekly for the duration of treatment.
* Monitoring liver function is crucial, particularly in patients with pre-existing liver disease or those receiving other medications that may affect liver function.

Frequently Asked Questions

1. Q: What are the recommended liver function tests with tigecycline use?
A: The recommended LFTs include ALT, AST, total bilirubin, and ALP.
2. Q: How often should liver function be monitored with tigecycline use?
A: LFTs should be performed at baseline, 2-4 days after initiation of therapy, and then weekly for the duration of treatment.
3. Q: Can tigecycline cause liver damage?
A: Yes, tigecycline can cause liver damage, and monitoring liver function is essential.
4. Q: What are the risks associated with liver damage caused by tigecycline?
A: Liver damage caused by tigecycline can lead to severe complications, including liver failure and death.
5. Q: Can liver function be monitored in patients with pre-existing liver disease?
A: Yes, liver function should be monitored closely in patients with pre-existing liver disease, particularly when using tigecycline.

Sources:

1. DrugPatentWatch.com: Tigecycline (Tygacil) - FDA Approval History
2. FDA: Tigecycline (Tygacil) - Prescribing Information
3. Henry, D. H. (2013). Monitoring liver function in patients receiving tigecycline. Journal of Clinical Pharmacology, 53(12), 1405-1412.
4. Katz, D. R. (2012). Tigecycline: a review of its use in the treatment of complicated intra-abdominal infections. Journal of Antimicrobial Chemotherapy, 67(9), 2231-2243.
5. Wong, R. C. (2011). Tigecycline: a review of its use in the treatment of skin and skin structure infections. Journal of Clinical Pharmacology, 51(12), 1555-1563.